Accesso Utente

Accedi con il tuo account personale per consultare i materiali riservati

  • Registrati
  • Nome utente dimenticato?
  • Password dimenticata?
  • Non hai ricevuto il link di attivazione?
Key Trials
  • HOME
  • PROGETTO
  • BOARD
  • PUBBLICAZIONI
ACCMED
  • Approfondimenti generali
  • Linee guida AIOM 2015 – Tumori del colon retto
    Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up E. Van Cutsem et al - Annals of Oncology 25 (Supplement 3): iii1–iii9, 2014
    eUpdate – Metastatic Colorectal Cancer Treatment Recommendations - Published: 20 September 2016. ESMO Guidelines Committee
    ClinicalTrial.gov. A service of the U.S. National Institutes of Health
  • Referenze bibliografiche specifiche
  • Petrelli F, et al. Prognostic Survival Associated With Left-Sided vs Right-Sided Colon Cancer: A Systematic Review and Meta-analysis. JAMA Oncol 2016.
    Chen K, et al. Primary tumor site is a useful predictor of cetuximab efficacy in the third-line or salvage treatment of KRAS wild-type (exon2 non-mutant) metastatic colorectal cancer: a nationwide cohort study. BMC Cancer 2016;16:327
    Jonker DJ, et al. Cetuximab for the Treatment of Colorectal Cancer. N Engl J Med 2007;357:2040-2048.
© 2016 - 2019 Accademia Nazionale di Medicina - Tutti i diritti riservati
To Top